CD4 and systemic sclerosis: Compared with IPF patients, SSc-ILD patients had more Th17 and Th22 cells in circulation [49], while RA-ILD patients had more B cells and CD4+ T cells in lung tissue than IPF patients, implying that CTD-ILD patients may be more prone to immune dysfunction than IPF patients [50].